Ulrike Bingel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ulrike Bingel has a total of 257 co-authors. Here are the top co-authors by number of shared publications:
- Balint Kincses
Department of Neurology, Center for Translational Neuro- and Behavioral Sciences, University Medicine Essen, Essen, Germany
13 shared publications - Katharina Schmidt
Department of Neurology, Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, University Duisburg-Essen
12 shared publications - Tamas Spisak
University Hospital Essen
12 shared publications - Katja Wiech
Department of Neurology, Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, University Duisburg-Essen
11 shared publications C. Büchel
8 shared publications- Julian Kleine-Borgmann
Department of Neurology, Center for Translational Neuro- and Behavioral Sciences, University Hospital Essen, University of Duisburg-Essen, Essen, Germany
8 shared publications
Latest Publications
- Open Access
Beyond pain: a brain-based biomarker predicts individual pain relief
Effective pain relief is a central goal of medical care, yet objective biomarkers of pain relief are lacking. Using task-based functional MRI and a capsaicin-induced tonic heat pain model, we experimentally elicited both pain exacerbation and pain relief within the same individuals. Existing brain-based signatures, including the Neurologic Pain Signature (NPS), reliably detected pain increases, but failed to capture pain relief. We therefore developed the PAin and RElief Signature (PARES), a multivariate brain signature trained to predict bidirectional changes in pain perception in n = 61 healthy controls. PARES robustly predicted both pain increases and relief and generalized to an independent cohort of people with chronic back pain (n = 58), who underwent the same experimental procedures. Together these findings establish a neural signature of pain relief and provide a potential biomarker for treatment stratification and analgesic development.
Open AccessBeyond pain: a brain-based biomarker predicts individual pain relief
Effective pain relief is a central goal of medical care, yet objective biomarkers of pain relief are lacking. Using task-based functional MRI and a capsaicin-induced tonic heat pain model, we experimentally elicited both pain exacerbation and pain relief within the same individuals. Existing brain-based signatures, including the Neurologic Pain Signature (NPS), reliably detected pain increases, but failed to capture pain relief. We therefore developed the PAin and RElief Signature (PARES), a multivariate brain signature trained to predict bidirectional changes in pain perception in n = 61 healthy controls. PARES robustly predicted both pain increases and relief and generalized to an independent cohort of people with chronic back pain (n = 58), who underwent the same experimental procedures. Together these findings establish a neural signature of pain relief and provide a potential biomarker for treatment stratification and analgesic development.
- Open Access
- 21 August 2026
- Published by Elsevier in Trends in Neurosciences
- Vol. 49 (9) , 709-719
Beyond Bayesian integration: how meaning shapes placebo effects
- 21 August 2026
- Published by Elsevier in Trends in Neurosciences
- Vol. 49 (9) , 709-719
Open AccessBeyond Bayesian integration: how meaning shapes placebo effects
- Open Access
Reinforcement Learning via Brain Feedback for real-time fMRI-based adaptive stimulus generation
Traditional fMRI studies rely on predefined task paradigms, where fixed stimulus designs limit the flexibility with which brain-stimulus relationships can be explored. Here, we introduce Reinforcement Learning via Brain Feedback (RLBF), a framework and open-source software package for adaptive stimulus optimization using real-time fMRI. RLBF reverses the conventional direction of inference by using neural responses to guide the exploration of stimulus spaces through reinforcement learning, enabling optimization of predefined brain targets such as regional activity or multivariate neural signatures. The accompanying Python-based software provides a modular framework integrating real-time fMRI data processing, reinforcement learning agents, adaptive stimulus generation, simulation-based testing, and experiment monitoring. Its flexible architecture allows researchers to customize preprocessing pipelines, reward functions, stimulus spaces, and RL strategies for diverse closed-loop neuroimaging applications. We validate the framework in a proof-of-concept study (N=10), demonstrating real-time optimization of a simple visual stimulus space by adapting checkerboard contrast and frequency to maximize primary visual cortex (V1) responses within a single 10-minute fMRI session. RLBF provides an extensible foundation for brain-guided stimulus optimization and enables new approaches for investigating neural specificity, individualized brain–stimulus relationships, and adaptive experimental design.
Open AccessReinforcement Learning via Brain Feedback for real-time fMRI-based adaptive stimulus generation
Traditional fMRI studies rely on predefined task paradigms, where fixed stimulus designs limit the flexibility with which brain-stimulus relationships can be explored. Here, we introduce Reinforcement Learning via Brain Feedback (RLBF), a framework and open-source software package for adaptive stimulus optimization using real-time fMRI. RLBF reverses the conventional direction of inference by using neural responses to guide the exploration of stimulus spaces through reinforcement learning, enabling optimization of predefined brain targets such as regional activity or multivariate neural signatures. The accompanying Python-based software provides a modular framework integrating real-time fMRI data processing, reinforcement learning agents, adaptive stimulus generation, simulation-based testing, and experiment monitoring. Its flexible architecture allows researchers to customize preprocessing pipelines, reward functions, stimulus spaces, and RL strategies for diverse closed-loop neuroimaging applications. We validate the framework in a proof-of-concept study (N=10), demonstrating real-time optimization of a simple visual stimulus space by adapting checkerboard contrast and frequency to maximize primary visual cortex (V1) responses within a single 10-minute fMRI session. RLBF provides an extensible foundation for brain-guided stimulus optimization and enables new approaches for investigating neural specificity, individualized brain–stimulus relationships, and adaptive experimental design.
- Open Access
- 10 August 2026
- Published by Wolters Kluwer Health in Pain
Methodological considerations for designing and conducting open-label placebo trials
In pain and other research fields, placebos have traditionally been associated with deception, although harnessing placebo effects does not necessarily require deception. Open-label placebos (OLPs) represent a novel approach in which inert treatments are administered openly and transparently, allowing patients to knowingly receive an inert treatment while still experiencing therapeutic benefits (eg, pain relief). As OLP research grows, concerns have been raised regarding methodological rigor and the unique challenges posed by unblinded designs in both experimental and clinical contexts. Given the inherent transparency regarding treatment group allocation in OLP trials, particular attention is needed when defining appropriate control groups, implementing feasible blinding strategies, and providing a treatment rationale to adequately explain OLPs. Addressing these challenges is crucial to advancing both the scientific understanding of the psychoneurobiological mechanisms underlying OLP effects and their clinical relevance in pain. In this review, we outline key methodological considerations for designing and conducting OLP studies in pain research and beyond, providing guidance on control group selection, blinding strategies, and reporting standards. In addition, we integrate insights from the patient advisory board of the transregional Collaborative Research Center (CRC/TRR) 289 “Treatment Expectation” to incorporate patient perspectives on the feasibility and acceptability of OLPs. Aligning study designs with patient needs and expectations may foster a more meaningful, patient-centered approach to OLP research. By combining methodological guidance and emphasizing patient-centered insights, this review aims to enhance the quality, relevance, and clinical translation of OLP research in pain.
- 10 August 2026
- Published by Wolters Kluwer Health in Pain
Open AccessMethodological considerations for designing and conducting open-label placebo trials
In pain and other research fields, placebos have traditionally been associated with deception, although harnessing placebo effects does not necessarily require deception. Open-label placebos (OLPs) represent a novel approach in which inert treatments are administered openly and transparently, allowing patients to knowingly receive an inert treatment while still experiencing therapeutic benefits (eg, pain relief). As OLP research grows, concerns have been raised regarding methodological rigor and the unique challenges posed by unblinded designs in both experimental and clinical contexts. Given the inherent transparency regarding treatment group allocation in OLP trials, particular attention is needed when defining appropriate control groups, implementing feasible blinding strategies, and providing a treatment rationale to adequately explain OLPs. Addressing these challenges is crucial to advancing both the scientific understanding of the psychoneurobiological mechanisms underlying OLP effects and their clinical relevance in pain. In this review, we outline key methodological considerations for designing and conducting OLP studies in pain research and beyond, providing guidance on control group selection, blinding strategies, and reporting standards. In addition, we integrate insights from the patient advisory board of the transregional Collaborative Research Center (CRC/TRR) 289 “Treatment Expectation” to incorporate patient perspectives on the feasibility and acceptability of OLPs. Aligning study designs with patient needs and expectations may foster a more meaningful, patient-centered approach to OLP research. By combining methodological guidance and emphasizing patient-centered insights, this review aims to enhance the quality, relevance, and clinical translation of OLP research in pain.
- Open Access
- 17 July 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 6538
Meta-analytic evidence for distinct neural correlates of conditioned versus verbally induced placebo analgesia
Placebo analgesia demonstrates that belief and expectation can significantly alter pain, even without active treatment. Placebo analgesia can be induced through verbal suggestion, classical conditioning, or their combination, though the role of conditioned neural responses above and beyond effects of verbal instructions remains unclear. We conduct a systematic meta-analysis of individual participant data from 16 within-participant placebo neuroimaging studies ( n = 409), employing univariate and multivariate analyses to identify shared and distinct mechanisms of placebo analgesia induced by suggestions alone versus suggestions combined with conditioning. Both techniques increase activity during pain in the dorsolateral prefrontal and inferior parietal cortices and decrease activation in the insula, putamen, and primary sensory areas. Adding conditioning enhances engagement of regions associated with context representation and pain modulation (e.g., dorsolateral/dorsomedial prefrontal cortices) and decreases in nociceptive regions (e.g., primary sensory and insular areas). Conditioning also strengthens the negative association between analgesia and nociceptive activity, as quantified by the Neurologic Pain Signature. Combining conditioning with instructions yields greater placebo analgesia, mediated by increased ventromedial prefrontal and dorsal caudate activity, alongside decreased sensory-nociceptive and cerebellar activity. These findings suggest the two strategies rely on partially distinct mechanisms in the brain.
- 17 July 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1) , 6538
Open AccessMeta-analytic evidence for distinct neural correlates of conditioned versus verbally induced placebo analgesia
Placebo analgesia demonstrates that belief and expectation can significantly alter pain, even without active treatment. Placebo analgesia can be induced through verbal suggestion, classical conditioning, or their combination, though the role of conditioned neural responses above and beyond effects of verbal instructions remains unclear. We conduct a systematic meta-analysis of individual participant data from 16 within-participant placebo neuroimaging studies ( n = 409), employing univariate and multivariate analyses to identify shared and distinct mechanisms of placebo analgesia induced by suggestions alone versus suggestions combined with conditioning. Both techniques increase activity during pain in the dorsolateral prefrontal and inferior parietal cortices and decrease activation in the insula, putamen, and primary sensory areas. Adding conditioning enhances engagement of regions associated with context representation and pain modulation (e.g., dorsolateral/dorsomedial prefrontal cortices) and decreases in nociceptive regions (e.g., primary sensory and insular areas). Conditioning also strengthens the negative association between analgesia and nociceptive activity, as quantified by the Neurologic Pain Signature. Combining conditioning with instructions yields greater placebo analgesia, mediated by increased ventromedial prefrontal and dorsal caudate activity, alongside decreased sensory-nociceptive and cerebellar activity. These findings suggest the two strategies rely on partially distinct mechanisms in the brain.
- Open Access
- 13 May 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1) , 241
Acute placebo responsiveness predicts longitudinal expectation effects in antidepressant treatment
Positive treatment expectations are known to enhance antidepressant efficacy. Experimental placebo studies aim to provide mechanistic insights into this association, yet their findings have not been clearly linked to clinical expectation effects within individual patients. In a randomized crossover trial, 61 participants with major depressive disorder (31 women, 30 men) completed an emotion classification task and mood assessments after administration of a saline nasal spray labeled as either oxytocin (sham oxytocin treatment, deceptive placebo) or saline (control). Forty-five participants subsequently underwent antidepressant treatment and were monitored weekly for treatment expectations and depressive symptoms, with follow-ups extending to three months. Using linear mixed-effect models, we examined trajectories of clinical expectation effects and their prediction by experimental placebo-induced changes in emotional processing. Sham oxytocin treatment acutely induced positive expectations, improved mood, and shifted emotional processing toward positivity. Longitudinal modeling revealed that weekly reductions in depressive symptoms were predicted by higher treatment expectations reported the preceding week. These clinical expectation effects were most pronounced in individuals exhibiting strong acute placebo responses in emotional processing. Overall, our findings indicate that positive treatment expectations facilitate critical aspects of emotional processing in depression and that individual responsiveness generalizes across different treatments and time windows. Experimental placebo assessments offer an ecologically valid model for elucidating mechanisms and predictors of clinical expectation effects and highlight expectation sensitivity as a promising target for treatment optimization.
- 13 May 2026
- Published by Springer Nature in Translational Psychiatry
- Vol. 16 (1) , 241
Open AccessAcute placebo responsiveness predicts longitudinal expectation effects in antidepressant treatment
Positive treatment expectations are known to enhance antidepressant efficacy. Experimental placebo studies aim to provide mechanistic insights into this association, yet their findings have not been clearly linked to clinical expectation effects within individual patients. In a randomized crossover trial, 61 participants with major depressive disorder (31 women, 30 men) completed an emotion classification task and mood assessments after administration of a saline nasal spray labeled as either oxytocin (sham oxytocin treatment, deceptive placebo) or saline (control). Forty-five participants subsequently underwent antidepressant treatment and were monitored weekly for treatment expectations and depressive symptoms, with follow-ups extending to three months. Using linear mixed-effect models, we examined trajectories of clinical expectation effects and their prediction by experimental placebo-induced changes in emotional processing. Sham oxytocin treatment acutely induced positive expectations, improved mood, and shifted emotional processing toward positivity. Longitudinal modeling revealed that weekly reductions in depressive symptoms were predicted by higher treatment expectations reported the preceding week. These clinical expectation effects were most pronounced in individuals exhibiting strong acute placebo responses in emotional processing. Overall, our findings indicate that positive treatment expectations facilitate critical aspects of emotional processing in depression and that individual responsiveness generalizes across different treatments and time windows. Experimental placebo assessments offer an ecologically valid model for elucidating mechanisms and predictors of clinical expectation effects and highlight expectation sensitivity as a promising target for treatment optimization.
- Open Access
Cerebellar activation in human placebo analgesia: Bridging findings from mice to humans
Placebo analgesia has traditionally been explained by top–down cortical regulation of brainstem and spinal pathways. Recent circuit-level work in animal models identified a rostral anterior cingulate–pontine–cerebellar pathway that contributes to expectation-based analgesia, implicating cerebellum circuits in placebo effects 1 . Building on these findings, we examined pontine and cerebellar contributions within a large individual-participant meta-analysis of human neuroimaging studies of placebo analgesia 2 ( n = 603). We found that the effects of human pain and placebo converge in cerebellar territories embedded in higher-order cognitive 3,4 and action-mode networks 5 . These regions exhibit placebo-induced anticipatory increases and reduced responses during painful stimulation, which correlate with the magnitude of placebo analgesia, consistent with predictive configuration of the system. Pontine responses also correlate with individual differences in placebo analgesia. In independent Human Connectome Project data ( n = 820), pontine activity is functionally connected with cingulate and cerebellar regions implicated in placebo analgesia. Together, these findings support a model in which expectation effects are implemented via predictive configuration of a cortico–pontine–cerebellar system.
Open AccessCerebellar activation in human placebo analgesia: Bridging findings from mice to humans
Placebo analgesia has traditionally been explained by top–down cortical regulation of brainstem and spinal pathways. Recent circuit-level work in animal models identified a rostral anterior cingulate–pontine–cerebellar pathway that contributes to expectation-based analgesia, implicating cerebellum circuits in placebo effects 1 . Building on these findings, we examined pontine and cerebellar contributions within a large individual-participant meta-analysis of human neuroimaging studies of placebo analgesia 2 ( n = 603). We found that the effects of human pain and placebo converge in cerebellar territories embedded in higher-order cognitive 3,4 and action-mode networks 5 . These regions exhibit placebo-induced anticipatory increases and reduced responses during painful stimulation, which correlate with the magnitude of placebo analgesia, consistent with predictive configuration of the system. Pontine responses also correlate with individual differences in placebo analgesia. In independent Human Connectome Project data ( n = 820), pontine activity is functionally connected with cingulate and cerebellar regions implicated in placebo analgesia. Together, these findings support a model in which expectation effects are implemented via predictive configuration of a cortico–pontine–cerebellar system.
- Open Access
- 18 March 2026
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
Functional connectivity-based attractor dynamics of the human brain in rest, task, and disease
Functional brain connectivity has been instrumental in uncovering the large-scale organization of the brain and its relation to various behavioral and clinical phenotypes. Understanding how this functional architecture relates to the brain’s dynamic activity repertoire is an essential next step towards interpretable generative models of brain function. We propose functional connectivity-based Attractor Neural Networks (fcANNs), a theoretically inspired model of macro-scale brain dynamics, simulating recurrent activity flow among brain regions based on first principles of self-organization. In the fcANN framework, brain dynamics are understood in relation to attractor states; neurobiologically meaningful activity configurations that minimize the free energy of the system. We provide the first evidence that large-scale brain attractors - as reconstructed by fcANNs - exhibit an approximately orthogonal organization, which is a signature of the self-orthogonalization mechanism of the underlying theoretical framework of free-energy-minimizing attractor networks. Analyses of seven distinct human neuroimaging datasets demonstrate that fcANNs can accurately reconstruct and predict brain dynamics under a wide range of conditions, including resting and task states, and brain disorders. By establishing a formal link between connectivity and activity, fcANNs offer a simple and interpretable computational alternative to conventional descriptive analyses.
- 18 March 2026
- Published by eLife Sciences Publications, Ltd in eLife
- Vol. 13
Open AccessFunctional connectivity-based attractor dynamics of the human brain in rest, task, and disease
Functional brain connectivity has been instrumental in uncovering the large-scale organization of the brain and its relation to various behavioral and clinical phenotypes. Understanding how this functional architecture relates to the brain’s dynamic activity repertoire is an essential next step towards interpretable generative models of brain function. We propose functional connectivity-based Attractor Neural Networks (fcANNs), a theoretically inspired model of macro-scale brain dynamics, simulating recurrent activity flow among brain regions based on first principles of self-organization. In the fcANN framework, brain dynamics are understood in relation to attractor states; neurobiologically meaningful activity configurations that minimize the free energy of the system. We provide the first evidence that large-scale brain attractors - as reconstructed by fcANNs - exhibit an approximately orthogonal organization, which is a signature of the self-orthogonalization mechanism of the underlying theoretical framework of free-energy-minimizing attractor networks. Analyses of seven distinct human neuroimaging datasets demonstrate that fcANNs can accurately reconstruct and predict brain dynamics under a wide range of conditions, including resting and task states, and brain disorders. By establishing a formal link between connectivity and activity, fcANNs offer a simple and interpretable computational alternative to conventional descriptive analyses.
- Open Access
- 12 January 2026
- Published by Wolters Kluwer Health in Pain
- Vol. 167 (5) , e71-e85
The effects of different types of pain modulation on social emotions and behaviour—a systematic literature review
Changes to one's pain processing system through external or cognitive influences may influence how we interact with other people. To investigate the causal effects of different pain modulations on social emotions and behaviour, we conducted a pre-registered PRISMA-guided systematic literature review. Our main aim was to investigate how directly or indirectly interfering with pain perception through (psycho)pharmacological manipulations affects our abilities to perceive, process, and react to positive and negative emotions (including pain) in other individuals. We included and synthesized 50 of 2060 screened studies. Included studies investigated the effects of opioids, opioid antagonists, acetaminophen, capsaicin, cannabinoids, ketamine, alcohol, placebo analgesia, and hypnotic analgesia. Overall risk of bias was low in 23, medium in 12, and high in 14 studies, while only 24% of studies checked whether their employed manipulation reduced first-hand pain (which it did in all of these). In summary, studies report inconsistent results, with findings generally showing small effects in both directions, ie, an increase or decrease of social emotions or abilities. The strongest and most consistent effect was observed for placebo analgesia decreasing empathy for pain. These results can be attributed to study heterogeneity, pharmacological effects, modes of action, as well as dosage differences. This review thus shows that we are far away from understanding the intricacies of different (psycho)pharmacological pain manipulations and their effects on social emotions and behaviour. To advance as a field and better understand the mechanisms of this interplay, we need well-powered studies, large-scale replications, and systematic meta-analyses.
- 12 January 2026
- Published by Wolters Kluwer Health in Pain
- Vol. 167 (5) , e71-e85
Open AccessThe effects of different types of pain modulation on social emotions and behaviour—a systematic literature review
Changes to one's pain processing system through external or cognitive influences may influence how we interact with other people. To investigate the causal effects of different pain modulations on social emotions and behaviour, we conducted a pre-registered PRISMA-guided systematic literature review. Our main aim was to investigate how directly or indirectly interfering with pain perception through (psycho)pharmacological manipulations affects our abilities to perceive, process, and react to positive and negative emotions (including pain) in other individuals. We included and synthesized 50 of 2060 screened studies. Included studies investigated the effects of opioids, opioid antagonists, acetaminophen, capsaicin, cannabinoids, ketamine, alcohol, placebo analgesia, and hypnotic analgesia. Overall risk of bias was low in 23, medium in 12, and high in 14 studies, while only 24% of studies checked whether their employed manipulation reduced first-hand pain (which it did in all of these). In summary, studies report inconsistent results, with findings generally showing small effects in both directions, ie, an increase or decrease of social emotions or abilities. The strongest and most consistent effect was observed for placebo analgesia decreasing empathy for pain. These results can be attributed to study heterogeneity, pharmacological effects, modes of action, as well as dosage differences. This review thus shows that we are far away from understanding the intricacies of different (psycho)pharmacological pain manipulations and their effects on social emotions and behaviour. To advance as a field and better understand the mechanisms of this interplay, we need well-powered studies, large-scale replications, and systematic meta-analyses.
- Open Access
- 10 December 2025
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 8 (1)
The impact of pain on memory: a study in chronic low back pain and migraine patients
Patients with chronic pain often complain of cognitive difficulties, such as ‘poor memory’. Both acute and chronic pain are thought to impair cognitive performance by demanding attentional and cognitive resources to the detriment of cognitive functioning. However, systematic experimental investigations in patients, as well as deeper understanding of factors that modulate these effects remain lacking. This study investigated whether patients with chronic migraine or patients with chronic low back pain are more susceptible to the disruptive effects of pain on memory as compared to pain-free healthy controls. Two groups of individuals with chronic pain (n = 55 patients with chronic migraine, n = 59 patients with chronic back pain) and n = 59 age-matched healthy controls, underwent experimental pain stimulation at either the back or head while performing a visual categorization and a subsequent recognition task. Pain-related cognitions and clinical parameters were assessed to explore their influence on pain-cognition interference. This large-scale experimental study revealed encouraging results regarding the impact of experimental pain on memory for the pain disorders studied here. Contrary to our hypothesis, patients with chronic migraine or chronic back pain showed no greater effects of experimental pain on recognition memory than healthy participants. Furthermore, the study showed no effect of stimulation site (i.e. head or lower back) or interaction with type of chronic pain. Pain-related cognitions, psychological variables and clinical parameters only had a marginal effect on pain-induced impairment of recognition memory in pain patients. Future research should focus on identifying cognitive and neural predictors associated with susceptibility or resilience to the disruptive effects of pain. Furthermore, larger and more diverse samples could enable person-centred methods to investigate how cognitive, clinical, and situational factors interact in shaping cognitive performance under pain. Such insights are crucial for the development of targeted, individualized therapeutic approaches in the management of chronic pain syndromes.
- 10 December 2025
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 8 (1)
Open AccessThe impact of pain on memory: a study in chronic low back pain and migraine patients
Patients with chronic pain often complain of cognitive difficulties, such as ‘poor memory’. Both acute and chronic pain are thought to impair cognitive performance by demanding attentional and cognitive resources to the detriment of cognitive functioning. However, systematic experimental investigations in patients, as well as deeper understanding of factors that modulate these effects remain lacking. This study investigated whether patients with chronic migraine or patients with chronic low back pain are more susceptible to the disruptive effects of pain on memory as compared to pain-free healthy controls. Two groups of individuals with chronic pain (n = 55 patients with chronic migraine, n = 59 patients with chronic back pain) and n = 59 age-matched healthy controls, underwent experimental pain stimulation at either the back or head while performing a visual categorization and a subsequent recognition task. Pain-related cognitions and clinical parameters were assessed to explore their influence on pain-cognition interference. This large-scale experimental study revealed encouraging results regarding the impact of experimental pain on memory for the pain disorders studied here. Contrary to our hypothesis, patients with chronic migraine or chronic back pain showed no greater effects of experimental pain on recognition memory than healthy participants. Furthermore, the study showed no effect of stimulation site (i.e. head or lower back) or interaction with type of chronic pain. Pain-related cognitions, psychological variables and clinical parameters only had a marginal effect on pain-induced impairment of recognition memory in pain patients. Future research should focus on identifying cognitive and neural predictors associated with susceptibility or resilience to the disruptive effects of pain. Furthermore, larger and more diverse samples could enable person-centred methods to investigate how cognitive, clinical, and situational factors interact in shaping cognitive performance under pain. Such insights are crucial for the development of targeted, individualized therapeutic approaches in the management of chronic pain syndromes.